SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Concord Drugs - Quaterly Results

11 Jan 2025 Evaluate
A decrease in the sales to Rs. 107.74 millions was observed for the quarter ended December 2024. The sales stood at Rs. 126.24 millions during the similar quarter previous year.The Total Profit for the quarter ended December 2024 of Rs. 2.22 millions grew from Rs.-2.39 millionsOP of the company witnessed a marginal growth to 13.14 millions from 5.62 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 107.74 126.24 -14.65 289.78 288.02 0.61 432.70 513.23 -15.69
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 13.14 5.62 133.81 28.50 34.98 -18.52 36.87 43.52 -15.28
Interest 4.26 4.32 -1.39 11.84 12.12 -2.31 15.90 16.24 -2.09
PBDT 8.88 1.30 583.08 16.66 22.86 -27.12 20.97 27.28 -23.13
Depreciation 3.67 3.85 -4.68 10.43 11.48 -9.15 15.38 16.03 -4.05
PBT 5.21 -2.55 -304.31 6.23 11.38 -45.25 5.59 11.25 -50.31
TAX 2.99 -0.16 -1968.75 3.34 3.63 -7.99 1.39 2.33 -40.34
Deferred Tax 1.55 -0.11 -1509.09 1.36 -0.54 -351.85 -0.63 -1.14 -44.74
PAT 2.22 -2.39 -192.89 2.89 7.75 -62.71 4.20 8.92 -52.91
Equity 100.00 100.00 0.00 100.00 100.00 0.00 100.00 93.16 7.34
PBIDTM(%) 12.20 4.45 173.96 9.84 12.14 -19.02 8.52 8.48 0.49

Concord Drugs Share Price

80.00 2.37 (3.05%)
15-Apr-2026 10:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.40
Dr. Reddys Lab 1214.10
Cipla 1223.90
Zydus Lifesciences 930.85
Lupin 2334.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×